Active Ingredient History
Bifidobacterium is a genus of gram-positive, nonmotile, often branched anaerobic bacteria. They are ubiquitous inhabitants of the gastrointestinal tract though strains have been isolated from the vagina and mouth of mammals, including humans. Bifidobacteria are one of the major genera of bacteria that make up the gastrointestinal tract microbiota in mammals. Some bifidobacteria are used as probiotics. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Antibiotic Prophylaxis (Phase 1)
Asthma (Phase 2/Phase 3)
Autism Spectrum Disorder (Phase 1/Phase 2)
Bacteremia (Phase 4)
Basal Ganglia Diseases (Phase 4)
Bifidobacterium (Phase 4)
Brain Diseases (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Carcinoma, Renal Cell (Phase 1/Phase 2)
Carcinoma, Transitional Cell (Phase 4)
Cardiovascular Diseases (Phase 1)
Central Nervous System Diseases (Phase 4)
Cervix Uteri (Phase 2)
Child (Phase 1)
Colitis, Ulcerative (Phase 2)
Colonic Polyps (Phase 4)
Colonoscopy (Phase 2)
Colorectal Neoplasms (Phase 1/Phase 2)
Communicable Diseases (Phase 4)
Constipation (Phase 3)
Cystitis (Phase 4)
Dental Caries (Phase 4)
Dermatitis, Atopic (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diarrhea (Phase 4)
Digestion ()
Drugs, Investigational (Phase 4)
Dyspepsia (Phase 4)
Enterocolitis, Pseudomembranous (Phase 4)
Esophageal Neoplasms (Phase 1/Phase 2)
Febrile Neutropenia (Phase 2)
Feces (Phase 4)
Fever (Phase 2)
Gastritis (Phase 3)
Gastroenteritis (Phase 4)
Gastrointestinal Microbiome (Phase 2)
Graves Disease (Phase 1/Phase 2)
Healthy Volunteers (Phase 3)
Heart Diseases (Phase 2)
Heart Failure (Phase 2)
Helicobacter pylori (Phase 4)
HIV (Phase 1/Phase 2)
Hypercholesterolemia (Phase 1)
Hyperglycemia (Phase 2)
Hypertension (Early Phase 1)
Infant, Premature (Phase 1)
Infections (Phase 2)
Influenza, Human (Phase 1)
Insulin Resistance (Phase 2)
Interleukin-17 (Phase 1/Phase 2)
Intestinal Diseases (Phase 1)
Intestinal Neoplasms (Phase 2)
Intra-Abdominal Fat (Phase 3)
Irritable Bowel Syndrome (Phase 4)
Kidney Failure, Chronic (Phase 2/Phase 3)
Kidney Transplantation (Early Phase 1)
Lichen Planus, Oral (Phase 2)
Live Birth (Phase 2)
Mania (Phase 2)
Melanoma (Phase 2)
Metabolic Syndrome (Phase 1/Phase 2)
Microsatellite Instability (Phase 1/Phase 2)
Movement Disorders (Phase 4)
Neoplasms (Phase 3)
Nervous System Diseases (Phase 4)
Neurodegenerative Diseases (Phase 4)
Neutropenia (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 1/Phase 2)
Obesity (Phase 3)
Oral Health (Phase 2/Phase 3)
Parkinson Disease (Phase 4)
Parkinsonian Disorders (Phase 4)
Pharyngitis (Phase 2)
Pneumonia (Phase 4)
Probiotics (Phase 4)
Respiratory Tract Infections (Phase 3)
Rhinitis, Allergic, Seasonal (Phase 3)
Signs and Symptoms, Digestive (Phase 1/Phase 2)
Stomatitis (Phase 3)
Stomatitis, Aphthous (Phase 2)
Subcutaneous Fat, Abdominal (Phase 3)
Surgical Wound Infection (Phase 4)
Triple Negative Breast Neoplasms (Phase 1/Phase 2)
Urinary Bladder Neoplasms (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue